Combined Impact of Smoking and Early Life Exposures on Adult Lung Function Trajectories by Allinson, JP et al.
1 
 
Combined Impact of Smoking and Early Life Exposures on 
Adult Lung Function Trajectories 
James P Allinson1, Rebecca Hardy2, Gavin C Donaldson1, Seif O Shaheen3, Diana Kuh2, 
Jadwiga A Wedzicha1 
1. Airways Disease Section, National Heart and Lung Institute, Imperial College London, 
United Kingdom 
2. MRC Unit for Lifelong Health and Ageing at UCL, London, United Kingdom 
3. Centre for Primary Care and Public Health, Barts and the London School of Medicine 
and Dentistry, Queen Mary University of London, United Kingdom 
 
Address correspondence to: 
Dr J.P. Allinson 
COPD Research Group, Airways Disease Section  
National Heart and Lung Institute 
Guy Scadding Building, Dovehouse Street, 
Imperial College London, United Kingdom 
SW3 6LY 
Phone: +44 207 5945665; E-mail: j.allinson@imperial.ac.uk 
 
Author contributions:  
J.P.A., R.H., G.C.D., S.O.S., D.K., and J.A.W. contributed to the content and writing of this 
manuscript. J.P.A. wrote the first draft of this manuscript. We all meet the definition of an 
author as stated by the International Committee of Medical Journal Editors, and we all have 
seen and approved the final manuscript. 
 
Funding:  
The MRC National Survey of Health and Development is funded by the UK Medical Research 
Council (MC_UU_12019/1, MC_UU_12019/2, MC_UU_12019/4). 
 
Running Title:  
Smoking, Early Life and Adult Lung Function 
 
Descriptor:  
9.6 COPD: Epidemiology 
 
Manuscript word count:  
3745 (excluding abstract) 
 
This article has an online data supplement, which is accessible from this issue's table of 
content online at www.atsjournals.org 
2 
 
At a Glance Commentary 
Scientific Knowledge on the Subject:  
Both low mid-life lung function and smoking-induced acceleration of adult FEV1 function decline can 
lead to COPD development. Current opinion advocates that adverse early life exposures correspond 
to lowered mid-life FEV1 because deficits established during early life track into adulthood. However, 
no lifelong study has reported how smoking across life may modify the impact of early life exposures 
upon adult lung function. 
 
What This Study Adds to the Field:  
This study analyses data collected prospectively across seven decades of life from a nationally 
representative sample of 2172 individuals, followed since their enrolment at birth during one week 
in March 1946. To our knowledge, this is the first study indicating that personal smoking behaviour 
modifies how adverse early life exposures, such as infant respiratory infection and early life home 
overcrowding, impact upon mid-life lung function and thereby influence adult lung function 
trajectory. Smoking can impair pulmonary development during adolescence/early adulthood and we 
propose this may also prevent recovery from early life deficits. These findings may partly explain the 
heterogeneity of lung function values among smokers and help identify individuals with greater 
susceptibility to developing respiratory conditions such as COPD. This study also reveals potential 
opportunities to avoid the conversion of early life disadvantage into adult pulmonary function 
deficits. 
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ABSTRACT 
BACKGROUND: Both adverse early life exposures and adult smoking can negatively 
influence adult lung function trajectory but few studies consider how the impact of early life 
exposures may be modified by subsequent smoking.  
METHODS: The Medical Research Council National Survey of Health and Development is a 
nationally representative cohort, initially of 5362 individuals, followed since enrolment at 
birth in March 1946. Using data collected prospectively across life and multilevel modelling 
we investigated how the relationships between early life exposures (infant lower respiratory 
infection, manual social class, home overcrowding and pollution exposure) and FEV1 and 
FVC trajectories between ages 43 and 60-64 were influenced by smoking behaviour. 
RESULTS: Among 2172 individuals, there were synergistic interactions of smoking with 
infant respiratory infection (P=0.04) and early life home overcrowding (P=0.009), for FEV1 at 
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43 years. Within smoker-stratified models, there were FEV1 deficits among ever-smokers 
associated with infant lower respiratory infection (-108.2ml; P=0.001) and home 
overcrowding (-89.2ml; P=0.002) which were not evident among never-smokers (-15.9ml; 
P=0.69 and -13.7ml; P=0.70 respectively). FVC modelling, including 1960 individuals, yielded 
similar results. FEV1 decline was greater in smokers (P<0.001) but there was no effect of any 
early life exposure on FEV1 decline. Neither smoking nor early life exposures were 
associated with FVC decline. 
CONCLUSIONS: Besides accelerating adult FEV1 decline, cigarette smoking also modifies how 
early life exposures impact upon both mid-life FEV1 and FVC. These findings are consistent 
with smoking impairing pulmonary development during adolescence or early adulthood 
thereby preventing catch-up from earlier acquired deficits. 
 
Abstract Word Count: 244 
Keywords:  Chronic Obstructive Pulmonary Disease;  
COPD development; Infancy; 
Childhood Respiratory Infections; 
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INTRODUCTION 
Lung function, commonly represented by forced expiratory volume in 1 second (FEV1) and 
forced vital capacity (FVC), peaks during the third decade of life and then declines with age 
(1). Both the peak values achieved, and subsequent rates of decline, determine adult lung 
function trajectory, which in turn influences both the development and progression of 
chronic obstructive pulmonary disease (COPD) (2-5). 
 
Adult lung function trajectories differ between individuals (2-4, 6, 7). By better 
understanding the origins of this variation we may be able to develop primary prevention 
strategies. Exposures across the whole life course can impact lung function, the extent of 
their impact influenced both by their nature and the stage of life during which they act (8). 
Early life represents a critical developmental period (4, 9) when exposures, such as 
respiratory infections (4), can impair lung function development. Furthermore, whereas 
smoking during adulthood is classically associated with the accelerated decline of FEV1 (7, 
10), smoking during adolescence can interfere with the final stages of pulmonary 
development influencing both FEV1 and FVC (11). Few of these studies, however, consider 
how smoking may modify the influence of early life exposures, or vice versa.  
 
The Medical Research Council (MRC) National Survey of Health and Development (NSHD) 
has followed a nationally representative sample of individuals for almost 70 years since 
birth, recording exposures during early life, their subsequent adult smoking behaviour and 
their adult lung function (12). This offers a unique opportunity to determine: (1) how the 
early environment influenced the risk of infant lower respiratory infection and adult 
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smoking; (2) how early life exposures impacted adult FEV1 and FVC level and decline 
between ages 43 and 60-64 and whether these relationships were modified by smoking. 
 
 
METHODS 
Population studied 
The NSHD is a study of 5362 individuals, representative of all single births to married women 
during one week in March 1946 within England, Scotland and Wales (12). Prospective data 
have been collected regularly from this nationally representative cohort of men and women 
since birth with participation rates of generally 80% or higher (13-15). At age 43 years, 3632 
were interviewed at home by research nurses. Loss to follow up was due to death (7%), 
emigration (11%), refusal (16%) and failure to trace (5%) (13). Similar visits were made at 
ages 53 (14) and at 60-64 years (15). At 60-64 the participating sample still remained 
broadly representative of native born British men and women of the same age (15). 
 
Data 
Lung Function 
Pre-bronchodilator lung function was measured at 43 (Mean: 43.5; Standard deviation(SD) 
0.2), 53 (Mean 43.5; SD 0.2) and 60-64 (Mean 63.3; SD 1.1) years, quality assured by trained 
nurses using the same Micro Medical Plus turbine electronic spirometers. Three 
manoeuvres were recorded in 1989 and two in 1999 and 2006-2011 but otherwise the same 
protocol, developed prior to the publication of the current ATS/ERS guidelines (16), was 
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followed at each visit. The largest of two reproducible readings, defined as within 150 
millilitres of each other, of FEV1 and FVC was used in analyses.  
 
Early Life Exposures 
Early life exposures refer to lower respiratory infection occurrence, home overcrowding, 
father’s social class and pollution exposure during infancy. When study members were two 
years old, their parents were asked by health visitors: “Has this baby ever had a lower 
respiratory infection – that is, bronchitis, bronchopneumonia or pneumonia” (17). The 
health visitors also recorded both the number of occupants and rooms within the home. 
Home overcrowding is defined as over one person per room (18, 19). Paternal occupational 
social class (grouped into manual vs non-manual) was recorded at age 4 years (or, if missing, 
at ages 11 or 15 years) (18). Pollution exposure estimates, based upon domestic local coal 
consumption at ages 0 and 2 years, were used to classify early life pollution exposure as 
either high or low (20). Maximal disadvantage in early life was defined as having had an 
infant lower respiratory tract infection, exposed to a high pollution level, living in an 
overcrowded home, and having a father with a manual occupation.  
 
Smoking history 
The number of cigarettes individuals smoked per day was recorded at 20, 25, 36, 43, 53 and 
60-64 years during nurse interviews or via postal questionnaires. Additionally, at age 20, 
prior smoking behaviour was recorded (including age of initiation) and at ages 36, 43, 53 
and 60-64, individuals were asked if they had ever previously smoked one or more 
cigarettes per day for one or more years. “Never-smokers” consistently denied ever 
regularly smoking throughout the study. Individuals smoking at least one cigarette per day 
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for at least one year were considered ever-smokers. For each individual providing smoking 
data at least at ages 20 and 43 years, we calculated an estimate of pack years accrued by 
age 43 years by multiplying the mean number of cigarettes smoked daily across ages 20, 25, 
36 and 43 years by 23 (number of intervening years) and then dividing by 20. Self-rolled 
cigarettes were converted: 1oz tobacco=25 manufactured cigarettes 
  
Other covariates 
Given their known associations with lung function, birth weight (4) (obtained from hospital 
records within a few weeks of birth) and both height (cm) and weight (kg) (16) (measured at 
age 43 years) and sex were pre-specified as covariates. Childhood asthma (defined by 
occurrence of asthma attacks at ages 6, 11 or 15 years) was considered a potential 
confounder. Parental smoking during an individual’s childhood (at age 53 years, individuals 
were asked if, during their childhood, their parents had smoked) was also considered a 
potential confounder.  
 
 
 
Data analysis 
2172 individuals (48% male) provided complete early life exposure data, sufficient smoking 
data to calculate pack years accrued by 43 years and reproducible FEV1 data with concurrent 
smoking data between ages 43 and 60-64. Of these, 1960 individuals also provided 
reproducible FVC data.  
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Early life exposures and risk of infant lower respiratory infection and adult smoking  
Chi-square tests and an independent t-test were used to investigate infant lower respiratory 
infection association with other early life exposures and birth weight respectively. 
Multivariable logistic regression models were used to investigate whether the relationships 
of childhood social class, overcrowding and pollution exposure with infant respiratory 
infection were independent of each other after also adjusting for sex and birth weight. Chi-
square tests were used to assess differences in ever-smoking according to sex and each 
early life exposure. Chi-square tests were also used to assess differences in early life 
exposures between individuals included versus not included in analyses.  
  
FEV1 and FVC at age 43 and decline according to early life exposures 
The relationship of early life exposure with FEV1 and FVC at age 43 and decline to 60-64 
years was analysed using multilevel models that account for repeated measures on the 
same individual. Random effects for both intercepts and slope were included allowing 
individual intercepts and slopes to vary.  
 
First, FEV1 change with age from 43 years onwards was modelled (Model 0).  Number of 
cigarettes smoked daily between ages 43 and 60-64 was then included as a time-varying 
covariate influencing both intercept and slope (by adding a smoking by age interaction) 
(Model 1). Different trajectories for men and women were then allowed (by adding sex and 
sex by age interaction) and adjustment was made for height and weight at age 43, pack 
years accrued by 43 years (a continuous variable) and birth weight. Each early life exposure 
(infant lower respiratory infection, father’s social class, home overcrowding and pollution 
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exposure) were added one at a time, and allowed to influence both intercept and slope 
(Models 2B). The final adjusted model included all early life exposures (Model 2A). We 
repeated this approach to investigate how early life exposures related to FVC at age 43 and 
decline to age 60-64. 
 
Modification of early life exposure influence on FEV1 and FVC trajectories by adult 
smoking 
Within the final adjusted FEV1 and FVC model we tested for interactions between each early 
life exposure and pack years accrued by 43 years. We then replaced pack years accrued by 
age 43 years and the number of cigarettes smoked daily between ages 43 and 60-64 with an 
ever-smoking covariate allowed to influence both intercept and slope, again testing for 
interactions with each early life exposure. Where there was evidence of effect modification, 
we stratified the sample by smoking status and subsequently fitted separate models in ever-
smokers and never-smokers. To illustrate the differences between smokers and never-
smokers, we plotted estimated mean FEV1 and FVC decline between 43 and 60-64 years for 
men of average height and weight who in early life were maximally disadvantaged versus 
those with no early life disadvantage. We investigated the effect of adjusting these models 
for childhood asthma. We also investigated the effect of adjusting these models for 
retrospectively reported parental smoking. 
  
To investigate whether data from previous studies supports the presence of an interaction 
between smoking and the infant respiratory infection, with regards to adult FEV1, we sought 
published studies reporting the adult FEV1 deficit (in millilitres or litres and with standard 
deviation reported) associated with prospectively recorded infant respiratory infection from 
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cohorts whose smoking prevalence was known. We classified these data according to how 
infant infection had been defined as follows: 1) occurrence of pneumonia (severe insult); 
occurrence of pneumonia, bronchitis or respiratory tract infection (includes more mild 
insults).  We used meta-regression, adjusting for the variance within each study, to test for a 
relationship between the magnitude of infection-associated FEV1 deficit and cohort smoking 
prevalence. 
 
Analyses were performed using SPSS version 22 (IBM Corporation, Armonk, NY) and STATA 
version 14 (Stata corporation, College Station, TX).  
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RESULTS 
Early life exposures and risk of infant lower respiratory infection and adult smoking  
Among the 2172 included in analyses, 26% experienced an infant lower respiratory 
infection, 57% belonged to manual social class households, 43% lived in overcrowded 
homes and 49% were exposed to high pollution with 6.2% subject to all (maximally 
disadvantaged) and 13.5% subject to none of these exposures (non-disadvantaged) (Figure 
1A). Mean birth weight was 3398g (Standard Deviation (SD) 508g). Within an adjusted 
model, infant lower respiratory infections were more likely within manual social class 
households, overcrowded homes and with high pollution exposure (Figure 1B & Table E1). 
No association was found with either sex or birth weight.  
 
1299 of these individuals (60%) had smoked by age 60-64 accruing (median) 9.6 (IQR: 3.1-
19.6) pack years by 43 years. 70% of smokers began smoking before age 20. Those from 
manual social class backgrounds more commonly became smokers (63%) than their non-
manual counterparts (56%; P<0.001) (Tables E2 and E4). Ever-smoking did not significantly 
differ according to infant lower respiratory infection, home overcrowding or pollution 
exposure. Males more commonly became smokers (66%) than females (54%; P<0.001). 
Those from manual social class backgrounds, from overcrowded homes or exposed to high 
pollution during early life were less likely to be included in analyses (Table E3).  
 
FEV1 and FVC at age 43 and decline according to early life exposures 
In models including only age (Figure E1&E2 Model 0), estimated mean FEV1 at age 43 was 
3.02 Litres, and mean FVC was 3.62 Litres. Overall, FEV1 declined by 24.8ml/yr (95%CI: 23.6 
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to 26.0) whilst FVC declined by 21.7ml/yr (95%CI: 19.8 to 23.6). In models including number 
of cigarettes smoked daily between ages 43 and 60-64 years (Figure E1&E2 Model 1), FEV1 
declined by an additional 0.5ml/yr/cigarette smoked daily (95%CI: 0.3 to 0.7) (P<0.001); 
equivalent to an estimated FEV1 decline of 33.9ml/year (95%CI: 30.6 to 37.2) among those 
smoking 20 cigarettes/day compared to 23.8ml/yr (95%CI: 22.5 to 25.1) among non-
smokers (P<0.001). In contrast, number of cigarettes smoked per day was not associated 
with decline in FVC (0.1ml/yr/cigarette smoked daily; 95%CI: 0.4 to -0.2; P=0.39).  
 
In models including sex, height and weight at 43 years, birth weight, pack years accrued by 
43 years and smoking between 43 and 64 years (Figure E1&E2 Model 2), no early life 
exposure was associated with decline in FEV1 or FVC. Within these models, FEV1 between 
ages 43 and 64 was lower in those who experienced infant lower respiratory infection (-
74.5ml; 95%CI: -123.2 to -25.9; P=0.003), home overcrowding (-60.3ml; 95%CI: -105.1 to -
15.5; P=0.01) and manual social class (-55.5ml; 95%CI: -100.3 to -9.8; P=0.02) (Figure E1 
Model 2A). At all ages, FVC deficits of similar magnitude were also associated with infant 
lower respiratory infection (-80.0ml; 95%CI: -147.7 to -12.2; P=0.02), home overcrowding (-
74.8ml; 95%CI: -137.2 to -12.5; P=0.02) and manual social class (-68.4ml; 95%CI: -131.3 to -
5.5; P=0.03) (Figure E2 Model 2A). Early life pollution exposure was not associated with 
either FEV1 or FVC.  
 
Modification of early life exposure influence on FEV1 and FVC trajectories by adult 
smoking 
An interaction was observed between pack years accrued by age 43 and both infant lower 
respiratory infection occurrence (P=0.04) and home overcrowding (P=0.009) for FEV1, such 
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that these adverse early exposures were more strongly associated with FEV1 in those with 
greater pack year exposure (Figure E1 Model 3). A similar interaction between pack years 
accrued and infant lower respiratory infection (P=0.02) was observed for FVC but the 
interaction was weaker for home overcrowding (P=0.16) (Figure E2 Model 3). We observed 
similar interactions between ever-smoking and both respiratory infection occurrence and 
home overcrowding with regards to FEV1 (P=0.03 and P=0.01 respectively) and FVC (P=0.03 
and P=0.35 respectively). There was no evidence of interaction between smoking and either 
social class or pollution exposure regarding FEV1 or FVC level. Tables 1 and 2 show adjusted 
FEV1 and FVC models for ever and never-smokers, respectively and Table E4 compares the 
characteristics of ever versus never smokers.  
 
Among ever-smokers each pack year accrued by 43 years was associated with an additional 
FEV1 decrease of 12.7ml (95%CI: 10.0 to 15.4; P<0.001) and a similar FVC decrement of 
12.8ml (95%CI: 9.4 to 16.2; P<0.001): equivalent to an estimated 292.1ml and 294.4ml lower 
FEV1 and FVC respectively for those smoking 20 cigarettes/day since age 20 years (23 pack 
years) (Tables 1A&1B). Number of cigarettes smoked per day between ages 43 and 60-64 
was associated with accelerated FEV1 but not FVC decline (Tables 1A&2A). 
 
Among ever-smokers lower FEV1 at age 43 was associated with infant lower respiratory 
infection occurrence (-108.2ml; 95%CI: -170.1 to -46.3; P=0.001), early life manual social 
class (-71.6ml; 95%CI: -130.1 to -13.2; P=0.02) and early life home overcrowding (-89.2ml; 
95%CI: -147.0 to -31.5; P=0.002) (Table 1A). Given the lack of association between these 
early life exposures and FEV1 decline, there was no evidence that their association with FEV1 
changed with age. There was no evidence of corresponding associations between early life 
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factors and FEV1 among the 873 never-smokers where all coefficients were much smaller 
(Table 1B). Table 2A shows FVC decrements of similar magnitude, which did not change with 
age, associated with infant lower respiratory infection (-117.3ml; 95%CI: -204.7 to -29.8; 
P=0.009) and early life home overcrowding (-93.1ml; 95%CI: -174.6 to -11.5; P=0.03) among 
ever-smokers. Again, among never-smokers all early life exposure coefficients were much 
smaller and non-significant (Table 2B). 
 
Figure 2 plots estimated FEV1 and FVC trajectories between 43 and 60-64 years for males (of 
mean height, weight and birth weight who were maximally disadvantaged versus non-
disadvantaged (regarding their early life exposures). This shows that the difference in mean 
FEV1 and FVC between the maximally and non-disadvantaged groups across all ages is 
considerably greater in smokers than non-smokers. Corresponding FEV1 and FVC trajectories 
from Figure 2 are plotted together in Figure 3 to illustrate how the combined impact of 
smoking and early life exposures influence the development of small lung volumes and 
airflow limitation (the latter characterised by FEV1/FVC<0.70). 
 
In the models stratified by smoking status, neither adjustment for childhood asthma (Figure 
E3) nor excluding the 75 individuals (3.5%) reporting asthma during childhood (Figure E4) 
changed the relationships observed between early life exposures and smoking with lung 
function trajectory. The association between childhood asthma and lower FEV1 was similar 
among never-smokers (-294.4ml; 95%CI: -452.4 to -136.3; P value<0.001) and ever-smokers 
(-275.0ml; 95%CI: -436.8 to -113.1; P=0.001). A similar, but non-significant trend was seen 
for FVC in both smokers and non-smokers. Appendix 1 also shows that adjustment for 
parental smoking history did not substantially change our results either. 
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Figure 4 shows the results of meta-regression analysis including data from this and five 
previous studies  (21-25), adjusting for the variance within each study, and suggests that the 
magnitude of pneumonia-associated deficits increases as cohort smoking prevalence 
increases (P=0.001). Deficits associated with more mildly defined respiratory infection 
follow a similar trend. Figure E5 contains details of studies included within this meta-
regression analysis. 
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DISCUSSION 
This study shows that individuals with adverse exposures during their early lives developed 
lower FEV1 and FVC values by age 43 years, but only if they had also become smokers. These 
deficits were independent of the additional reduction in both FEV1 and FVC level 
accompanying each pack year already smoked. Subsequently, between ages 43 and 60-64 
years, FEV1 decline was accelerated by smoking, but was not influenced by early life 
exposures. Neither smoking nor early life exposures influenced FVC decline. 
 
Many studies suggest early life exposures influence adult respiratory health (6, 26) but the 
NSHD is the first to prospectively study a nationally representative sample of individuals 
continuously from birth into their seventh decade, thereby minimising the recall bias (26) 
affecting retrospective studies of early life (2, 7, 27-30). Uniquely, the NSHD has 
documented, during early life, each individual’s exposures and then serially recorded 
smoking behaviour across adult life. This allows us to study how the influence of early life 
exposures may change and be changed by smoking during adulthood. In contrast to other 
studies, recruitment following birth within the same week in March 1946 removes the need 
to adjust for age (7, 31) or symptomatic recruitment bias (7, 32) and together with the 
inclusion of both men and woman (7, 21) from rural and urban areas (32) makes this study 
more generalizable.  
 
Current opinion advocates that adverse early life experiences, such as respiratory infections, 
correspond to diminished mid-life FEV1 because deficits established during early-life track 
into adulthood (6, 33) yet at 43 years of age we found such deficits only among those who 
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had also smoked. A similar interaction between early life, subsequent smoking and adult 
respiratory health has been previously reported (29). Furthermore, whilst most prospective 
studies simply adjust for smoking (21-24, 33-36), the existence of the interaction between 
smoking and infant respiratory infection, appears consistent with how the adult FEV1 deficit 
associated with infant respiratory infection relates to cohort smoking prevalence, as 
observed across this and five previous major prospective studies (21-25), shown in Figure 4. 
Analysis by meta-regression, adjusted for the variance within each study, showed that the 
magnitude of pneumonia-associated deficits increases as cohort smoking prevalence 
increases (P=0.001). Deficits associated with more mildly defined respiratory infection 
follow a similar trend. Explaining the basis of this interaction might extend our 
understanding of both individual smoking susceptibility and the long-term impact of early 
life environment. 
 
In agreement with most others, we found no evidence of a relationship between early life 
exposures and rate of adult lung function decline (29, 35). Additionally, our finding that 
adverse early life exposures among smokers were associated with similar decrements in 
both FEV1 and FVC at age 43 years is consistent with these individuals having developed 
smaller-sized lungs. Together, these observations favour an underlying mechanism of 
impaired development rather than accelerated adult decline (35). which may partly explain 
the spectrum of FEV1 values observed among adult smokers with similar FEV1 decline rates 
(2). 
 
The lack of evidence of early life associated pulmonary deficits among never-smokers in 
mid-life also suggests that instead of deficits simply tracking from infancy, smoking modifies 
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how early life exposures impact upon lung development. Within the NSHD, smoking 
commonly started during adolescence (37), a period when marked FEV1 and FVC growth (1) 
is known to permit some recovery from pulmonary function deficits acquired earlier in life 
(32, 38). However, smoking during this late stage of pulmonary growth impairs both FEV1 
and FVC development (11). Smoking during adolescence may thereby prevent catch-up 
growth and hence recovery from earlier acquired deficits, perhaps explaining why deficits 
were only apparent among smokers. 
 
Smoking after age 43 was associated with accelerated FEV1, but not FVC decline, 
theoretically favouring the development of airflow limitation, as illustrated in figure 3. 
Although the similar lowering of FEV1 and FVC at age 43 years we found associated with 
early life adversity would not itself result in airflow limitation, the reduced respiratory 
reserve would predispose to a more severe grade of COPD if airflow limitation were to 
subsequently develop, as illustrated in figures 2 and 3. 
 
Although manual social class and home overcrowding, both indicators of lower income, 
overlap considerably, their independent associations with later pulmonary deficits suggest 
that they reflect different inequalities in household resources, behaviour or environment 
(18) Together with high pollution exposure, they also predispose infants to respiratory 
infections (17, 18) which are historically linked to COPD development (2). Whether this link 
relates to a common predisposition, such as pre-existing small airways, or to the infective 
event itself, perhaps involving viral sensitisation remains unclear (6, 26). Since the inception 
of this study seven decades ago, multiple additional perinatal and prenatal determinants of 
health, such as maternal nutrition, have been identified (4, 39), and these exposures may 
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underpin some of the associations relating to , for example, occupational social class. 
Confirmation of both the long-term impact of more recently implicated exposures, and the 
pattern of childhood lung function upon adult health, awaits the maturation of subsequent 
birth cohorts recording both these exposures and lung function across childhood towards 
peak adult function. However, by showing how smoking may modify the impact of early life, 
our study identifies a novel perspective from which future investigators may approach such 
data. In the meantime, our findings provide scope for practical intervention by public health 
policy makers, especially among adolescent smokers who often believe that cessation at a 
later stage will still avert significant damage (40).   
 
A major strength of our study is that individuals were followed from birth into their sixties 
but this long study period also presents several limitations. Firstly, the NSHD protocol was 
designed before guidelines promoting post bronchodilator spirometry measurements, 
potentially leading to some underestimation of values. Nevertheless, misclassification of 
post-bronchodilator lung function is likely to be random with respect to the exposures of 
interest (and vice versa), which would be expected to lead to underestimation of effect 
estimates.  
 
Secondly, delineating the impact of infant life upon adult life necessitates lifelong studies, 
yet long-running studies inevitably incur losses to follow-up over time. Despite NSHD 
participation rates generally remaining at 80% or higher throughout the study (12, 41) those 
with early life disadvantages were less likely to continue to participate, due to both the 
excess mortality (42) and other attrition. Nevertheless, our study sample has remained 
broadly nationally representative (15) suggesting survival to adulthood within the cohort 
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reflects survival amongst the wider population. Whilst we cannot rule out the possibility 
that this might have introduced bias regarding adult spirometry data, we cannot see why 
the associations under investigation would be different between those who were, and were 
not, included in the analyses or how this could undermine the applicability of our findings to 
adult survivors from this generation within the general population.  
 
Finally, the cohort sample is representative of those born in one week in March 1946 in 
England Scotland and Wales whose early life exposures reflect those of their generation. 
Today, although living conditions in these countries have improved, poverty and infant 
respiratory infection remain major issues, particularly across the developing world where 
smoking prevalence is climbing. Additionally, technologies which have improved survival 
among subsequent generations, for example following premature birth, may inadvertently 
lead to the emergence of previously absent adult vulnerabilities with their origins in early 
life. Furthermore, although smoking prevalence in developed countries is in decline, 
potential new adult hazards are emerging, for example electronic cigarette usage. 
Therefore, the importance of a healthy environment across the life course needs to be 
championed to prevent unnecessary morbidity. 
 
An important consideration is the complex, potentially reciprocal, relationship between 
childhood asthma and respiratory infections (22). Childhood asthma prevalence within the 
NSHD corresponds to other studies of this time (43) as do the size of the asthma associated 
adult pulmonary function deficits (44). These deficits occurred irrespective of smoker status 
and neither the exclusion of childhood asthmatics, nor adjustment for childhood asthma 
significantly altered our findings. Consequently, childhood asthma appears an unlikely 
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mediator of the interaction detected between smoking and early life exposures, however, 
this does not preclude a role for airway hyperactivity or undiagnosed asthma which will 
remain key areas of future research.  
 
In summary, this lifelong nationally representative prospective study indicates that besides 
accelerating adult FEV1 decline, cigarette smoking also modifies how early life exposures 
impact upon both mid-life FEV1 and FVC. Our findings are consistent with smoking impairing 
pulmonary development during adolescence or early adulthood thereby preventing catch-
up from earlier acquired deficits. Whilst individuals cannot choose their early life exposures, 
by choosing not to smoke, they may avoid converting early life disadvantage into adult 
pulmonary function deficits. 
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FIGURE 1: The relationship between infant lower respiratory infection and father’s occupational 
class, home overcrowding and high pollution exposure during early life among those individuals 
providing complete data during early life (N=2172) within the MRC National Survey of Health and 
Development. 
A: Venn diagram representing the overlapping prevalence (%) of infant lower respiratory infection, 
father’s occupational class, home overcrowding and high pollution exposure during early life. 
Numbers shown are percentages of the included population (N=2172). *Represents those with no 
lower respiratory infection, father from non-manual occupational class, no home overcrowding and 
low pollution exposure during early life. 
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B: Associations of infant lower respiratory infection, by father’s occupational class, home 
overcrowding and pollution exposure adjusting for male sex and birth weight. Odds ratios (95% CIs) 
of having an infant lower respiratory infection according to the presence of each factor calculated 
using a multiple logistic regression model including all variables mentioned.  
Definitions: CI = confidence interval.  
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TABLE 1: The estimated associations between early life factors and adult FEV1 between ages 43 and 
60-64 years from multilevel models including all variables listed in the table (coefficients for linear 
change are from risk factor by age interactions) among A: ever-smokers (smoked at some point by 
age 60-64 years) and B: never-smokers (never smoked up to age 60-64 years). In models including 
only age (Figure E1 Model 0), estimated mean FEV1 at age 43 was 3.02 Litres with overall FEV1 
declined of 24.8ml/yr (95%CI: 23.6 to 26.0). 95%CI = 95% Confidence Interval. See also Figures 2, 3 & 
E1. 
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Table 2: The estimated associations between early life factors and adult FVC decline trajectory 
between ages 43 and 60-64 years from multilevel models including all variables listed in the table 
among A: ever-smokers (smoked at some point by age 60-64 years) and B: never-smokers (never 
smoked up to age 60-64 years). In models including only age (Figure E2 Model 0), estimated mean 
FVC at age 43 was 3.62 Litres with overall FVC decline of 21.7ml/yr (95%CI: 19.8 to 23.6). 95%CI = 
95% Confidence Interval. See also Figures 2, 3 & E2. 
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FIGURE 2: A comparison of the estimated average (A) FEV1 and (B) FVC trajectories between ages 43 
and 60-64 years for males of average height at age 43 years (175cm), weight at age 43 years (78 kg) 
and birth weight (3.5kg) according to adult smoking behaviour and early life disadvantage. Estimated 
level and slope between 43 and 60-64 years of age calculated using multilevel models (Tables 1 and 
2). Predicted FEV1 and FVC values according to age calculated as per Hankinson et al.(16) 
Never-smoker = never smoked up to age 60-64 years. Adult-smoker = smoking 20 cigarettes per day 
from age 20 years until 60-64 years. Non-disadvantaged early life = no lower respiratory infection, 
father’s non-manual social class, non-overcrowded home and low pollution exposure during early 
life. Maximally disadvantaged early life = lower respiratory infection present, father’s manual social 
class, overcrowded home and high pollution exposure during early life. 
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FIGURE 3: A comparison of the estimated pattern of FEV1 decline in relation to FVC decline between 
ages 43 and 60-64 years for males of average height at age 43 years (175cm), average weight at age 
43 years (78 kg) and average birth weight (3.5kg) according to adult smoking behaviour and early life 
disadvantage. Estimated level and slope between 43 and 60-64 years of age calculated using 
multilevel models (Tables 1 and 2). Blue shaded area indicates zone within which FEV1 values would 
meet traditional airflow limitation criteria (FEV1/FVC<0.7) associated with COPD diagnosis. See 
Figure E5 for accompanying FEV1 /FVC plots. 
Never-smoker = never smoked up to age 60-64 years. Adult-smoker = smoking 20 cigarettes per day 
from age 20 years until 60-64 years. Non-disadvantaged early life = no lower respiratory infection, 
non-manual social class, non-overcrowded home and low pollution exposure during early life. 
Maximally disadvantaged early life = lower respiratory infection present, manual social class, 
overcrowded home and high pollution exposure during early life. 
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FIGURE 4: The relationship between the deficit in adult FEV1 associated with early life respiratory 
infection and the prevalence of ever-smoking among study members.  
The data shown are taken from the NSHD and six other major prospective studies. The graph 
suggests that the adult FEV1 deficit associated with infant pneumonia (red markers) increases in 
magnitude as the prevalence of smoking within a study increases. A similar trend is seen across 
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studies reporting the decrement associated with a milder definition of infant respiratory infection 
(blue markers), including “bronchitis”, “respiratory tract infection” rather than just pneumonia. For 
details of included studies see figure E5. Lines fitted using 
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